- Home
- HCI vs QDEL Comparison
HCI vs QDEL Comparison
Compare HCI & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCI
- QDEL
- Stock Information
- Founded
- HCI 2006
- QDEL 1979
- Country
- HCI United States
- QDEL United States
- Employees
- HCI N/A
- QDEL N/A
- Industry
- HCI Property-Casualty Insurers
- QDEL Medical Specialities
- Sector
- HCI Finance
- QDEL Health Care
- Exchange
- HCI Nasdaq
- QDEL Nasdaq
- Market Cap
- HCI 1.7B
- QDEL 1.9B
- IPO Year
- HCI N/A
- QDEL N/A
- Fundamental
- Price
- HCI $180.63
- QDEL $28.57
- Analyst Decision
- HCI Strong Buy
- QDEL Buy
- Analyst Count
- HCI 4
- QDEL 6
- Target Price
- HCI $181.25
- QDEL $40.17
- AVG Volume (30 Days)
- HCI 124.7K
- QDEL 1.1M
- Earning Date
- HCI 11-06-2025
- QDEL 11-06-2025
- Dividend Yield
- HCI 0.88%
- QDEL N/A
- EPS Growth
- HCI N/A
- QDEL N/A
- EPS
- HCI 11.47
- QDEL N/A
- Revenue
- HCI $775,545,000.00
- QDEL $2,741,600,000.00
- Revenue This Year
- HCI $19.33
- QDEL N/A
- Revenue Next Year
- HCI $10.92
- QDEL $3.40
- P/E Ratio
- HCI $15.88
- QDEL N/A
- Revenue Growth
- HCI 9.67
- QDEL N/A
- 52 Week Low
- HCI $91.06
- QDEL $22.05
- 52 Week High
- HCI $183.31
- QDEL $49.45
- Technical
- Relative Strength Index (RSI)
- HCI 74.70
- QDEL 55.04
- Support Level
- HCI $172.25
- QDEL $27.45
- Resistance Level
- HCI $183.12
- QDEL $29.25
- Average True Range (ATR)
- HCI 4.61
- QDEL 1.20
- MACD
- HCI 0.96
- QDEL 0.13
- Stochastic Oscillator
- HCI 89.06
- QDEL 52.68
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.